Liver function in early congenital syphilis: does penicillin cause a deterioration?

Area of Science:

• Neonatal Medicine
• Pediatric Infectious Diseases
• Clinical Immunology

Background:

• Congenital syphilis poses risks to neonates, including potential liver involvement.
• The impact of standard penicillin treatment on neonatal liver function requires clarification.
• The role of immune complexes in congenital syphilis pathogenesis is not fully understood.

Purpose of the Study:

• To investigate if penicillin therapy deteriorates liver function in neonates with congenital syphilis.
• To assess the relationship between circulating immune complexes and liver involvement.
• To evaluate the efficacy of steroid therapy as an adjunct to penicillin for congenital syphilis.

Main Methods:

• Prospective study of 30 neonates with clinical congenital syphilis.
• Random assignment into penicillin-only and penicillin-plus-prednisone groups.
• Comparison with 21 asymptomatic infants born to seropositive mothers (control group).
• Monitoring of liver function tests, blood counts, and immunological markers up to 3 months of age.

Main Results:

• No significant differences in measured parameters between penicillin-only and penicillin-plus-prednisone groups.
• Penicillin therapy did not correlate with deteriorating liver function or increased immune complexes.
• Prednisone as an adjunct therapy did not alter any studied parameters compared to penicillin alone.

Conclusions:

• Penicillin therapy is safe regarding liver function in neonates with congenital syphilis.
• Circulating immune complexes do not appear directly linked to penicillin treatment or liver involvement.
• Adjunct steroid therapy offers no additional benefit in managing liver function or immune markers in this context.